派姆单抗-话题@MedSci

#派姆单抗#

82篇内容 | 3734人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1253444, encodeId=e21b125344458, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：派姆单抗联合培美曲塞-铂类治疗非鳞状非小细胞肺癌的患者自评预后, objectType=article, longId=187873, objectId=612818e8732b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=612818e8732b, replyNumber=0, likeNumber=77, createdTime=2020-02-13, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=612818e8732b, moduleTitle=Lancet oncol：派姆单抗联合培美曲塞-铂类治疗非鳞状非小细胞肺癌的患者自评预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=612818e8732b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253443, encodeId=db9c12534435b, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：派姆单抗治疗儿科各类肿瘤的疗效, objectType=article, longId=184764, objectId=fb23184e6498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb23184e6498, replyNumber=0, likeNumber=76, createdTime=2019-12-15, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb23184e6498, moduleTitle=Lancet oncol：派姆单抗治疗儿科各类肿瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb23184e6498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253442, encodeId=27d912534429f, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=J Clin Oncol：派姆单抗治疗难治性转移去势抵抗性前列腺癌研究, objectType=article, longId=184303, objectId=d805184303b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d805184303b6, replyNumber=0, likeNumber=72, createdTime=2019-12-07, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d805184303b6, moduleTitle=J Clin Oncol：派姆单抗治疗难治性转移去势抵抗性前列腺癌研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d805184303b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253441, encodeId=3d561253441f7, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Prostate Cancer P D：派姆单抗加前列腺冷冻疗法治疗新诊断低转移激素敏感性前列腺癌的初步研究, objectType=article, longId=181974, objectId=06361819e47a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06361819e47a, replyNumber=0, likeNumber=77, createdTime=2019-10-28, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06361819e47a, moduleTitle=Prostate Cancer P D：派姆单抗加前列腺冷冻疗法治疗新诊断低转移激素敏感性前列腺癌的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06361819e47a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253440, encodeId=ce09125344053, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Blood：派姆单抗单药治疗RRcHL可获得持久的缓解, objectType=article, longId=177653, objectId=fb891e765330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb891e765330, replyNumber=0, likeNumber=84, createdTime=2019-08-16, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb891e765330, moduleTitle=Blood：派姆单抗单药治疗RRcHL可获得持久的缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb891e765330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253439, encodeId=00cb12534393a, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=NEJM：派姆单抗治疗进行性多灶性白质脑病, objectType=article, longId=164971, objectId=83ba1649e171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ba1649e171, replyNumber=0, likeNumber=102, createdTime=2019-04-26, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ba1649e171, moduleTitle=NEJM：派姆单抗治疗进行性多灶性白质脑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ba1649e171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253438, encodeId=78861253438c2, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=NEJM：派姆单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌疗效比较, objectType=article, longId=162681, objectId=6ab8162681a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ab8162681a7, replyNumber=0, likeNumber=120, createdTime=2019-03-22, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ab8162681a7, moduleTitle=NEJM：派姆单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ab8162681a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253437, encodeId=d489125343e20, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=NEJM：派姆单抗联合化疗对鳞状非小细胞肺癌的疗效分析, objectType=article, longId=154161, objectId=4aa0154161dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4aa0154161dc, replyNumber=0, likeNumber=132, createdTime=2018-11-23, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4aa0154161dc, moduleTitle=NEJM：派姆单抗联合化疗对鳞状非小细胞肺癌的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4aa0154161dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253436, encodeId=96df1253436d9, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, objectType=article, longId=148662, objectId=655114866244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=655114866244, replyNumber=0, likeNumber=61, createdTime=2018-09-13, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=655114866244, moduleTitle=Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=655114866244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253435, encodeId=bbe41253435aa, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳, objectType=article, longId=140045, objectId=0720140045ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0720140045ca, replyNumber=0, likeNumber=59, createdTime=2018-06-07, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0720140045ca, moduleTitle=Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0720140045ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253434, encodeId=3f961253434ef, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：派姆单抗用于晚期肝细胞癌患者疗效显著, objectType=article, longId=139950, objectId=3e4013995040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e4013995040, replyNumber=0, likeNumber=81, createdTime=2018-06-06, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e4013995040, moduleTitle=Lancet oncol：派姆单抗用于晚期肝细胞癌患者疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e4013995040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253433, encodeId=b3ca125343333, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=EUR J Cancer：派姆单抗诱导的致命性多发性肌炎, objectType=article, longId=130893, objectId=2d4d1308934b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d4d1308934b, replyNumber=0, likeNumber=120, createdTime=2018-03-01, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d4d1308934b, moduleTitle=EUR J Cancer：派姆单抗诱导的致命性多发性肌炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d4d1308934b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253432, encodeId=1218125343207, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=EUR J Cancer：派姆单抗相关的严重眼肌麻痹, objectType=article, longId=130892, objectId=b0c113089237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0c113089237, replyNumber=0, likeNumber=0, createdTime=2018-03-01, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0c113089237, moduleTitle=EUR J Cancer：派姆单抗相关的严重眼肌麻痹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0c113089237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253431, encodeId=cc5b12534317b, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：阿西替尼联合派姆单抗治疗晚期肾细胞癌患者的安全性和效果, objectType=article, longId=129653, objectId=ed1312965394, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed1312965394, replyNumber=0, likeNumber=66, createdTime=2018-02-13, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed1312965394, moduleTitle=Lancet oncol：阿西替尼联合派姆单抗治疗晚期肾细胞癌患者的安全性和效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed1312965394)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253430, encodeId=37eb125343057, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性, objectType=article, longId=128001, objectId=1589128001e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1589128001e0, replyNumber=0, likeNumber=73, createdTime=2018-01-29, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1589128001e0, moduleTitle=Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1589128001e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253429, encodeId=4ddd12534290d, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳, objectType=article, longId=122519, objectId=7e5f122519c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e5f122519c5, replyNumber=0, likeNumber=63, createdTime=2017-12-08, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e5f122519c5, moduleTitle=JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e5f122519c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253428, encodeId=021512534285f, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=JNCI：转移性NSCLC：派姆单抗个体化剂量还是固定剂量性价比更高？, objectType=article, longId=118185, objectId=799c1181855c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=799c1181855c, replyNumber=0, likeNumber=85, createdTime=2017-11-01, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=799c1181855c, moduleTitle=JNCI：转移性NSCLC：派姆单抗个体化剂量还是固定剂量性价比更高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=799c1181855c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253427, encodeId=81c8125342e5c, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, objectType=article, longId=114396, objectId=95c311439626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95c311439626, replyNumber=0, likeNumber=84, createdTime=2017-09-28, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95c311439626, moduleTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95c311439626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253426, encodeId=4f5c1253426b7, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究, objectType=article, longId=111067, objectId=776311106e61, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=776311106e61, replyNumber=0, likeNumber=66, createdTime=2017-08-29, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776311106e61, moduleTitle=JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776311106e61)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1253425, encodeId=9ce2125342559, content=<a href='/topic/show?id=1c4e65265d5' target=_blank style='color:#2F92EE;'>#派姆单抗#</a>, objectTitle=J Clin Oncol：派姆单抗治疗化疗耐药转移性绒癌生化完全缓解, objectType=article, longId=107463, objectId=277010e46350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=277010e46350, replyNumber=0, likeNumber=77, createdTime=2017-08-03, rootId=0, userName=jianjun66, userId=ce5632, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=277010e46350, moduleTitle=J Clin Oncol：派姆单抗治疗化疗耐药转移性绒癌生化完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=277010e46350)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

派姆单抗

2020-05-29

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：派姆单抗联合培美曲塞-铂类治疗非鳞状非小细胞肺癌的患者自评预后

2020-02-13

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：派姆单抗治疗儿科各类肿瘤的疗效

2019-12-15

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

J Clin Oncol：派姆单抗治疗难治性转移去势抵抗性前列腺癌研究

2019-12-07

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Prostate Cancer P D：派姆单抗加前列腺冷冻疗法治疗新诊断低转移激素敏感性前列腺癌的初步研究

2019-10-28

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Blood：派姆单抗单药治疗RRcHL可获得持久的缓解

2019-08-16

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

NEJM：派姆单抗治疗进行性多灶性白质脑病

2019-04-26

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

NEJM：派姆单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌疗效比较

2019-03-22

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

NEJM：派姆单抗联合化疗对鳞状非小细胞肺癌的疗效分析

2018-11-23

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性

2018-09-13

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet：派姆单抗单药二线治疗胃以及胃食管交界癌效果不佳

2018-06-07

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：派姆单抗用于晚期肝细胞癌患者疗效显著

2018-06-06

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

EUR J Cancer：派姆单抗诱导的致命性多发性肌炎

2018-03-01

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

EUR J Cancer：派姆单抗相关的严重眼肌麻痹

2018-03-01

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：阿西替尼联合派姆单抗治疗晚期肾细胞癌患者的安全性和效果

2018-02-13

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：派姆单抗用于治疗晚期胸腺癌的效果和安全性

2018-01-29

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳

2017-12-08

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

JNCI：转移性NSCLC：派姆单抗个体化剂量还是固定剂量性价比更高？

2017-11-01

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。

2017-09-28

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究

2017-08-29

jianjun66 (审核中...)

前往app查看评论内容

#派姆单抗#

J Clin Oncol：派姆单抗治疗化疗耐药转移性绒癌生化完全缓解

2017-08-03

科室
- - 订阅+
  - 更多科室
工具
服务